The TriALTIS is a posterior thoracolumbar pedicle screw system that has a comprehensive implant portfolio and instruments designed to work with enabling technology, according to a news release. The system aims to address clinical needs in complex spine surgery.
TriALTIS earned FDA clearance in October.
“The TriALTIS spine system marks a significant stride in the future of surgical excellence, and we’re excited to continue to pioneer innovation that helps to advance the treatment of complex spine conditions for surgeons and their patients,” DePuy Synthes Worldwide President of Spine Russell Powers said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
